We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-3.85%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$140B
AUM Growth
+$5.37B
Cap. Flow
+$13.5B
Cap. Flow %
9.64%
Top 10 Hldgs %
30.28%
Holding
6,714
New
321
Increased
2,151
Reduced
2,607
Closed
759

Sector Composition

Rank Sector Weight
1 Technology 8.94%
2 Healthcare 5.53%
3 Financials 5.03%
4 Consumer Discretionary 4.6%
5 Industrials 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEI
5126
Solaris Energy Infrastructure
SEI
$2.9B
$4K ﹤0.01%
478
-1,578
-77% -$16.2K
BCOV
5127
DELISTED
Brightcove, Inc.
BCOV
$4K ﹤0.01%
622
-2,175
-78% -$14.1K
WEL
5128
DELISTED
Integrated Wellness Acquisition Corp
WEL
$4K ﹤0.01%
+400
New +$4.02K
OMIC
5129
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$4K ﹤0.01%
57
-112
-66% -$11.7K
ALPN
5130
DELISTED
Alpine Immune Sciences Inc
ALPN
$4K ﹤0.01%
619
-978
-61% -$8.06K
IRRX.WS
5131
CALL
DELISTED
Integrated Rail and Resources Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
IRRX.WS
$4K ﹤0.01%
50,001
NEPT
5132
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$4K ﹤0.01%
64
+63
+6,300% +$4.3K
LFACW
5133
CALL
DELISTED
LF Capital Acquisition Corp. II Warrants
LFACW
$4K ﹤0.01%
50,001
GFGDW
5134
CALL
DELISTED
The Growth for Good Acquisition Corporation Warrant
GFGDW
$4K ﹤0.01%
53,645
LTCH
5135
DELISTED
Latch, Inc. Common Stock
LTCH
$4K ﹤0.01%
4,145
-1,318
-24% -$1.51K
CVT
5136
DELISTED
Cvent Holding Corp. Common Stock
CVT
$4K ﹤0.01%
689
-4,147
-86% -$23.6K
HZON
5137
DELISTED
Horizon Acquisition Corporation II
HZON
$4K ﹤0.01%
363
SHQAW
5138
CALL
DELISTED
Shelter Acquisition Corporation I Warrants
SHQAW
$4K ﹤0.01%
50,001
AFACW
5139
CALL
DELISTED
Arena Fortify Acquisition Corp. Warrant
AFACW
$4K ﹤0.01%
50,001
ACIU icon
5140
AC Immune
ACIU
$236M
$3K ﹤0.01%
918
-285
-24% -$898
AKYA
5141
DELISTED
Akoya BioSciences
AKYA
$3K ﹤0.01%
252
-771
-75% -$10.2K
AMTX icon
5142
Aemetis
AMTX
$104M
$3K ﹤0.01%
448
-1,939
-81% -$14.8K
LONA
5143
LeonaBio Inc
LONA
$65.5M
$3K ﹤0.01%
97
-933
-91% -$32.2K
ATOM icon
5144
Atomera
ATOM
$187M
$3K ﹤0.01%
310
-1,030
-77% -$12.2K
ATRO icon
5145
Astronics
ATRO
$3.37B
$3K ﹤0.01%
460
-1,752
-79% -$14.6K
AVAH icon
5146
Aveanna Healthcare
AVAH
$2.15B
$3K ﹤0.01%
1,810
-3,535
-66% -$7.26K
AVDL
5147
DELISTED
Avadel Pharmaceuticals
AVDL
$3K ﹤0.01%
659
-200
-23% -$1.1K
BBCP icon
5148
Concrete Pumping Holdings
BBCP
$513M
$3K ﹤0.01%
398
-1,515
-79% -$10.2K
BBW icon
5149
Build-A-Bear
BBW
$443M
$3K ﹤0.01%
216
-600
-74% -$9.39K
BCML icon
5150
BayCom
BCML
$335M
$3K ﹤0.01%
196
-970
-83% -$18.7K

Similar funds

Citigroup's Q3 2022 Portfolio in Review

As of Q3 2022, Citigroup held 6,714 positions worth $140B, up 4% from $134B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Citigroup deployed $13.5B of net new capital in Q3 2022, opening 321 new positions and adding to 2,151 existing holdings. Its largest new stake was Invesco S&P SmallCap Information Technology ETF: 420,000 shares worth $15.5M.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 10% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.31B trimmed.

  • Citigroup's largest Q3 2022 buy was Invesco S&P SmallCap Information Technology ETF: 420,000 shares worth $15.5M.
  • Citigroup added most to Lowe's Companies in Q3 2022, an estimated $539M increase.
  • Citigroup's biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.31B.
  • Citigroup fully exited GCP Applied Technologies Inc. in Q3 2022, selling an estimated $18.7M.
  • Citigroup's ten largest holdings make up 30% of its $140B portfolio in Q3 2022.
  • Citigroup opened 321 new positions and closed 759 in Q3 2022.
  • Citigroup's portfolio value rose 4% quarter-over-quarter to $140B.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.